home / stock / kykof / kykof short
Short Information | Kyowa Hakko Kogyo (OTCMKTS:KYKOF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 19,049 |
Total Actual Volume | 35,167 |
Short Trends | |
---|---|
Cover Days | 2 |
Short Days | 18 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 952 |
Average Short Percentage | 79.75% |
Is there a KYKOF Short Squeeze or Breakout about to happen?
See the KYKOF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-05-2024 | $17.75 | $17.8 | $17.8 | $17.75 | 411 | 411 | 100% |
07-03-2024 | $17.25 | $17.25 | $17.25 | $17.25 | 311 | 311 | 100% |
06-28-2024 | $18.262 | $17.25 | $18.262 | $17.25 | 544 | 544 | 100% |
06-24-2024 | $0 | $17 | $0 | $0 | 81 | 1 | 1.23% |
06-21-2024 | $17.321 | $17 | $17.321 | $17 | 254 | 254 | 100% |
06-20-2024 | $16.07 | $16.07 | $16.07 | $16.07 | 500 | 322 | 64.4% |
06-17-2024 | $0 | $17.798 | $0 | $0 | 40 | 40 | 100% |
06-14-2024 | $17.59 | $17.798 | $17.798 | $17.265 | 29,240 | 15,340 | 52.46% |
06-11-2024 | $0 | $17.2 | $0 | $0 | 2 | 2 | 100% |
05-14-2024 | $17.759 | $17.759 | $17.759 | $17.759 | 219 | 129 | 58.9% |
05-13-2024 | $0 | $17.335 | $0 | $0 | 10 | 10 | 100% |
05-06-2024 | $17.335 | $17.335 | $17.335 | $17.335 | 301 | 301 | 100% |
04-11-2024 | $0 | $17.74 | $0 | $0 | 1,491 | 91 | 6.1% |
04-09-2024 | $0 | $17.74 | $0 | $0 | 91 | 91 | 100% |
04-03-2024 | $17.74 | $17.74 | $17.74 | $17.74 | 957 | 557 | 58.2% |
04-02-2024 | $0 | $18.1 | $0 | $0 | 75 | 55 | 73.33% |
04-01-2024 | $0 | $18.1 | $0 | $0 | 55 | 55 | 100% |
03-25-2024 | $18.1 | $18.1 | $18.1 | $18.1 | 255 | 205 | 80.39% |
03-21-2024 | $19.45 | $19.45 | $19.45 | $19.45 | 100 | 100 | 100% |
03-20-2024 | $0 | $19.89 | $0 | $0 | 230 | 230 | 100% |
News, Short Squeeze, Breakout and More Instantly...
Kyowa Hakko Kogyo Company Name:
KYKOF Stock Symbol:
OTCMKTS Market:
TOKYO , Jan. 6, 2020 /PRNewswire/ -- Kyowa Kirin Co., Ltd. (TSE: 4151) President and CEO: Masashi Miyamoto , "Kyowa Kirin") today announces that its marketing authorisation application (MAA) for istradefylline (KW-6002) as an adjunctive treatment to levodopa-based regimens in adult patie...